|OPK -- Israel Stock|| |
ILS 860.50 23.00 2.75%
Analysis of Opko Health manpower and management performance can provide insight into Opko Health stock performance. Also an employee sentiment is becoming a valuable factor that investors can use to determine the amount of risk that may be associated with Opko Health future performance. Opko Health employes about 5690 people. The company is managed by 20 executives with total tenure of roughly 140 years, averanging almost 7.0 years of service per executive having 1.0 employee per reported executive. Additionally take a look at Your Equity Center
| ||Jon Cohen Chairman|
Executive Chairman of BioReference Laboratories
Opko Health Management Effectiveness
The company has return on total asset (ROA)
of (4.0) %
which means that it has lost $4.0 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of (8.42) %
meaning that it generated substantial loss on money invested by shareholders.
Opko Health Workforce Comparison
Opko Health is considered to be number one stock in number of employees category among related companies. The total workforce
of Drug Manufacturers - Specialty & Generic
industry is now estimated at about 11,380. Opko Health totals roughly 5,690 in number of employees claiming about 50% of equities under Drug Manufacturers - Specialty & Generic industry.
Opko Health Profit Margins
The company has Profit Margin (PM) of (15.45) %
which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (16.29) %
which suggests for every $100 dollars of sales it generated a net operating loss of -0.16.
Opko Health Stakeholders